Are anxiety disorders undertreated in patients with multiple sclerosis?
Dag Aarsland* and Nanna Figved
Correspondence *Stavanger University Hospital, Centre for Clinical Neuroscience Research, PO Box 8100, 4068 Stavanger, Norway
Email daa@sus.no
This article has no abstract so we have provided the first paragraph of the full text.
Neuropsychiatric symptoms are common in patients with MS, and they have important implications for functioning and quality of life.1 Few studies have explored psychiatric symptoms other than depression in MS. Previous studies of anxiety disorders in MS used self-report rating scales to evaluate anxiety, and thus diagnoses of anxiety disorder could not be made. Furthermore, self-report might be an unreliable method of assessing mental symptoms in patients with MS because of disease-associated factors such as cognitive impairment and personality changes, including euphoria and reduced insight and judgement.2
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.